Guidance maps clearance process for trials of knee cartilage products

01/20/2012 | MassDevice.com (Boston)

New guidance from the FDA outlines the process for obtaining clearance for clinical studies of devices, combination products and biologics designed to replace or repair knee cartilage. The guidance requires manufacturers seeking investigational device exemption to submit documents describing materials used, individual elements, anticipated product changes and related data.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA